BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10419702)

  • 1. In search of the true sentinel node by different injection techniques in breast cancer patients.
    Roumen RM; Geuskens LM; Valkenburg JG
    Eur J Surg Oncol; 1999 Aug; 25(4):347-51. PubMed ID: 10419702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients.
    Maza S; Thomas A; Winzer KJ; Hüttner C; Blohmer JU; Hauschild M; Richter M; Krössin T; Geworski L; Zander A; Guski H; Munz DL
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):671-5. PubMed ID: 14745517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification.
    Valdés-Olmos RA; Jansen L; Hoefnagel CA; Nieweg OE; Muller SH; Rutgers EJ; Kroon BB
    J Nucl Med; 2000 Sep; 41(9):1500-6. PubMed ID: 10994729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.
    Feggi L; Basaglia E; Corcione S; Querzoli P; Soliani G; Ascanelli S; Prandini N; Bergossi L; Carcoforo P
    Eur J Nucl Med; 2001 Nov; 28(11):1589-96. PubMed ID: 11702098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradermal radioisotope injection is superior to subdermal injection for the identification of the sentinel node in breast cancer patients.
    Motomura K; Komoike Y; Hasegawa Y; Kasugai T; Inaji H; Noguchi S; Koyama H
    J Surg Oncol; 2003 Feb; 82(2):91-6; discussion 96-7. PubMed ID: 12561063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoscintigraphy in breast cancer patients--comparison of peritumoural and intradermal injection.
    Rettenbacher L; Kässmann H; Galvan G; Menzel C; Reitsamer R; Holzmannhofer J
    Nuklearmedizin; 2000 Sep; 39(6):152-5. PubMed ID: 11057406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of technical and clinical variables affecting sentinel node localization in patients with breast cancer after a single intradermal injection of 99mTc nanocolloidal albumin.
    Rubello D; Zavagno G; Bozza F; Lise M; De Salvo GL; Saladini G; Mariani G; Casara D
    Nucl Med Commun; 2004 Nov; 25(11):1119-24. PubMed ID: 15577591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritumoural versus subareolar administration of technetium-99m nanocolloid for sentinel lymph node detection in breast cancer: preliminary results of a prospective intra-individual comparative study.
    Maza S; Valencia R; Geworski L; Zander A; Guski H; Winzer KJ; Munz DL
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):651-6. PubMed ID: 12612811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoscintigraphy and SPECT/CT in multicentric and multifocal breast cancer: does each tumour have a separate drainage pattern? Results of a Dutch multicentre study (MULTISENT).
    Brouwer OR; Vermeeren L; van der Ploeg IM; Valdés Olmos RA; Loo CE; Pereira-Bouda LM; Smit F; Neijenhuis P; Vrouenraets BC; Sivro-Prndelj F; Jap-a-Joe SM; Borgstein PJ; Rutgers EJ; Oldenburg HS
    Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1137-43. PubMed ID: 22526968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary lymph node drainage pathways from intradermal and intraparenchymal breast planes.
    Fowler JC; Solanki CK; Ballinger JR; Ravichandran D; Douglas-Jones A; Lawrence D; Bobrow L; Purushotham AD; Peters AM
    J Surg Res; 2010 Jun; 161(1):69-75. PubMed ID: 19439325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contribution of nuclear medicine to lymphatic mapping and sentinel node identification in oncology].
    Valdés Olmos RA; Jansen L; Muller SH; Hoefnagel CA; Nieweg O
    Rev Esp Med Nucl; 1999; 18(2):111-21. PubMed ID: 10352326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plurifocal breast cancer and double lymphatic spread.
    Ruggiero R; Procaccini E; Cuccurullo V; Mansi L; Gili S; Cremone C; Docimo G; Docimo L; Sparavigna L; Gubitosi A; Iovino F; Parmeggiani D; Avenia N
    G Chir; 2008 Oct; 29(10):424-6. PubMed ID: 18947466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-visualization of sentinel lymph node in patients with breast cancer.
    Krausz Y; Ikeda DM; Jadvar H; Langleben D; Birdwell R; Strauss HW
    Nucl Med Commun; 2001 Jan; 22(1):25-32. PubMed ID: 11233548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Less axillary dissection necessary due to sentinel node biopsy in patients with breast carcinoma].
    Meijer S; Collet GJ; Pijpers HJ; van Hattum L; Hoekstra OS
    Ned Tijdschr Geneeskd; 1996 Nov; 140(45):2239-43. PubMed ID: 8984370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
    Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
    Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.
    De Cicco C; Cremonesi M; Luini A; Bartolomei M; Grana C; Prisco G; Galimberti V; Calza P; Viale G; Veronesi U; Paganelli G
    J Nucl Med; 1998 Dec; 39(12):2080-4. PubMed ID: 9867145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subdermal re-injection: a method to increase surgical detection of the sentinel node in breast cancer without increasing the false-negative rate.
    Bajén MT; Benítez A; Mora J; Ricart Y; Ferran N; Guirao S; Carrera D; Gil M; Pla MJ; Gumá A; Palacin JA; Martin-Comin J
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):338-43. PubMed ID: 16307292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with intradermal injection and intradermal-plus-deep injection in the radioguided sentinel node biopsy of early breast cancer patients.
    Koizumi M; Koyama M; Yamashita T; Tada KI; Nishimura SI; Takahashi K; Makita M; Iwase T; Yoshimoto M; Kasumi F
    Eur J Surg Oncol; 2006 Sep; 32(7):738-42. PubMed ID: 16806793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer.
    Pijpers R; Meijer S; Hoekstra OS; Collet GJ; Comans EF; Boom RP; van Diest PJ; Teule GJ
    J Nucl Med; 1997 Mar; 38(3):366-8. PubMed ID: 9074519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technical aspects of sentinel node lymphoscintigraphy for breast cancer.
    Dunnwald LK; Mankoff DA; Byrd DR; Anderson BO; Moe RE; Yeung RS; Eary JF
    J Nucl Med Technol; 1999 Jun; 27(2):106-11. PubMed ID: 10353106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.